For people with obstructive sleep apnea who can’t tolerate CPAP or BiPAP — even at high pressures — hearing “you might be a candidate for Inspire” often raises more questions than it answers. Here’s a general, hedge-your-bets overview of what the therapy actually is, who it tends to be considered for, and what the research says about outcomes, so you can have a more informed conversation with your sleep specialist.
What Inspire actually is
Inspire is a surgically implanted device — sometimes described as an “upper airway stimulation” system — that the Cleveland Clinic explains works differently from CPAP: instead of pushing air through the airway, it delivers mild stimulation to the hypoglossal nerve (which controls tongue movement) in sync with breathing, gently moving the tongue and other soft tissues out of the way so the airway stays open during sleep. It’s controlled with a small handheld remote that’s typically switched on before bed and off after waking.
Who tends to be considered a candidate
According to the Mayo Clinic’s overview of hypoglossal nerve stimulation, candidacy generally depends on factors like apnea severity, body mass index, and airway anatomy determined through a procedure called drug-induced sleep endoscopy (DISE) — not simply “CPAP didn’t work for me.” The American Academy of Sleep Medicine (AASM) and device-maker clinical criteria generally describe candidates as adults with moderate-to-severe obstructive sleep apnea who have tried and struggled with CPAP, and who don’t have a specific pattern of total airway collapse (concentric collapse at the soft palate) identified during DISE — which is why the evaluation process, not just AHI severity alone, matters so much before anyone is confirmed as a good fit.
What the evidence says about outcomes
Long-term follow-up data, including a study published via the National Library of Medicine (PubMed) tracking outcomes several years post-implant, has generally shown meaningful reductions in AHI (apnea-hypopnea index) and improvements in daytime sleepiness scores for appropriately selected patients, with most reporting they’d choose the therapy again. That said, “appropriately selected” is doing a lot of work in that sentence — outcomes research on Inspire, like most device studies, tends to reflect people who passed the DISE screening criteria, which is part of why patient experiences reported informally can vary more widely than the published outcome averages.
Known considerations discussed by the Cleveland Clinic and Mayo Clinic include a recovery period after the implant surgery, an adjustment/titration period after activation (the stimulation level is typically increased gradually over weeks), and — as with any implanted device — surgical and device-related risks that are worth reviewing directly with the surgical team.
Questions worth bringing to your sleep specialist
- Has drug-induced sleep endoscopy (DISE) been done, and what did it show about your specific collapse pattern?
- What does your AHI, BMI, and anatomy suggest about expected outcome likelihood in your specific case?
- What does the post-implant titration and follow-up schedule typically look like at this center?
This article is for general educational purposes only and does not constitute medical advice. Whether Inspire — or any other treatment for obstructive sleep apnea — is appropriate for you depends on your individual diagnostic workup and should be decided with your sleep medicine physician and surgical team.
— Gemifys
